Literature DB >> 15580360

[Increasing importance of opioids in geriatrics].

M Schuler1, P Oster.   

Abstract

BACKGROUND: During the previous 20 years the prescription of opioids for medical use has increased steadily. Patients and professionals have great reservations about the use of opioids in the elderly. The aim of this study was to describe the changes in analgesic therapy in a geriatric clinic during the previous 10 years.
METHOD: The quality and quantity of prescriptions for opioids as well as the costs of the analgesic therapy in a large geriatric clinic between 1994 and 2003 were analyzed.
RESULTS: The use of opioids increased steadily from 0.72 mg per day and patient in 1994 to 9.50 mg in 2003 (1320%). The introduction of sustained release tilidine/naloxone and tramadol led to a change of the prescribed forms but only to a slight increase in the total consumption of these drugs. In 1994 the average daily cost of analgesic therapy was 15 cents per patient compared with 46 cents in 2003. The percentage of analgesics in the pharmacological budget increased from 5.6 to 10.8%.
CONCLUSION: Dealing with opioids should be a part of the training program for all members of the geriatric team. Analgesics have come to play an important role in the pharmacological budget at least in this geriatric clinic.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15580360     DOI: 10.1007/s00482-004-0377-4

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


  17 in total

Review 1.  Proximal femoral fracture: achievements and prospects.

Authors:  C A Austin; P J Lawson; R Gibson; I Philp
Journal:  Age Ageing       Date:  1998-11       Impact factor: 10.668

2.  Influence of age on pain relief from analgesics. A study of postoperative patients.

Authors:  J W Bellville; W H Forrest; E Miller; B W Brown
Journal:  JAMA       Date:  1971-09-27       Impact factor: 56.272

3.  Age is the best predictor of postoperative morphine requirements.

Authors:  P E Macintyre; D A Jarvis
Journal:  Pain       Date:  1996-02       Impact factor: 6.961

4.  Accumulation of normeperidine, an active metabolite of meperidine, in patients with renal failure of cancer.

Authors:  H H Szeto; C E Inturrisi; R Houde; S Saal; J Cheigh; M M Reidenberg
Journal:  Ann Intern Med       Date:  1977-06       Impact factor: 25.391

5.  A randomized trial of comprehensive geriatric assessment and home intervention in the care of hospitalized patients.

Authors:  T Nikolaus; N Specht-Leible; M Bach; P Oster; G Schlierf
Journal:  Age Ageing       Date:  1999-10       Impact factor: 10.668

6.  [Problems recognizing pain in geriatrics].

Authors:  M Schuler; M Hestermann; K Hauer; G Schlierf; P Oster
Journal:  Schmerz       Date:  2002-06       Impact factor: 1.107

Review 7.  Quality improvement guidelines for the treatment of acute pain and cancer pain. American Pain Society Quality of Care Committee.

Authors: 
Journal:  JAMA       Date:  1995-12-20       Impact factor: 56.272

8.  [Satisfaction of geriatric patients with their pain therapy. Wish and reality].

Authors:  M Schuler; D Razus; P Oster; K Hauer
Journal:  Schmerz       Date:  2004-08       Impact factor: 1.107

9.  [Case management and functional outcome in persons aged 65 years and over with hip fracture].

Authors:  N Specht-Leible; U Schultz; B Kraus; P J Meeder; A Quentmeier; V Ewerbeck; E Voss; M Martin; P Oster
Journal:  Unfallchirurg       Date:  2003-03       Impact factor: 1.000

10.  [Therapy with opioids in liver or renal failure].

Authors:  I Tegeder; G Geisslinger; J Lötsch
Journal:  Schmerz       Date:  1999-06-11       Impact factor: 1.107

View more
  2 in total

1.  [Opioids for noncancer pain in the elderly].

Authors:  M Schuler; N Grießinger
Journal:  Schmerz       Date:  2015-08       Impact factor: 1.107

2.  [Complaints under analgesics: the difficult interpretation by older patients].

Authors:  M Schuler; D Razus; P Oster
Journal:  Schmerz       Date:  2009-04       Impact factor: 1.107

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.